Company intelligence / Profile preview

Teralys Capital

Montreal, Quebec, Canadateralyscapital.com ↗

Ownership: Private
Development stage: Other

Overview

Teralys Capital is Canada’s largest innovation-focused fund of funds manager. It finances private venture capital funds investing in information technologies, life sciences (including biotech and healthcare), and cleantech. With over $2 billion CAD under management across multiple specialized venture capital fund-of-funds portfolios since its founding in 2009, it has exposure to more than 60 underlying VC funds and over 700 portfolio companies. Its investments span early-stage startups through growth-stage technology buyouts across North America and Europe[1][3][5].

Industry: Investors

Partnerships

Eli Lilly & Company (co-investment partnership for TVM Life Science Ventures VII)

Beyond the preview

Go deeper on Teralys Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Teralys Capital.

Explore the full profile